Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Behavioral Program and Topiramate for Migraine in ED
NCT02643719Withdrawn
- Sponsor
- NYU Langone Health
- Start
- Dec 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of topiramate in migraine, sponsored by NYU Langone Health. Primary endpoints: Verbal Numeric Rating Scale at 72 hours and Headache Impact Test at 3 months. Planned start Dec 2015; status: withdrawn.
02
Drugs
topiramate
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02643719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02643719.